Amylyx Pharmaceuticals (AMLX) Return on Sales Growth (1y) (2022 - 2025)
Amylyx Pharmaceuticals (AMLX) Return on Sales Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.00 |
| 10 | Amylyx Pharmaceuticals | 1.94 Bn | 1.94 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 310.00 |
| Jun 30, 2025 | 637.00 |
| Mar 31, 2025 | -193.00 |
| Dec 31, 2024 | -40.00 |
| Sep 30, 2024 | -175.00 |
| Jun 30, 2024 | -71.00 |
| Mar 31, 2024 | -1.00 |
| Dec 31, 2023 | 2.00 |
| Sep 30, 2023 | 156.00 |
| Sep 30, 2022 | -75.00 |